Devleeschouwer N - Search Results

1

Hormone sensitivity in vitro and in vivo of v-ras-transfected MCF-7 cell derivatives.

Van Roy F, Mareel M, Vleminckx K, Beyaert R, Fiers W, Devleeschouwer N, Muquardt C, Legros N, Bracke M, Leclercq G. Van Roy F, et al. Among authors: devleeschouwer n. Int J Cancer. 1990 Sep 15;46(3):522-32. doi: 10.1002/ijc.2910460332. Int J Cancer. 1990. PMID: 2203690

2

Estrogen receptor status and estradiol sensitivity of MCF-7 cells in exponential growth phase.

Madeddu L, Legros N, Devleeschouwer N, Bosman C, Piccart MJ, LeClercq G. Madeddu L, et al. Among authors: devleeschouwer n. Eur J Cancer Clin Oncol. 1988 Mar;24(3):385-90. doi: 10.1016/s0277-5379(98)90007-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383942

3

Estrogen conjugates and serum factors mediating the estrogenic trophic effect on MCF-7 cell growth.

Devleeschouwer N, Legros N, Olea-Serrano N, Paridaens R, Leclercq G. Devleeschouwer N, et al. Cancer Res. 1987 Nov 15;47(22):5883-7. Cancer Res. 1987. PMID: 3664489

4

Endocrine effects of Trilostane: in vitro and in vivo studies.

Tueni E, Devleeschouwer N, Leclercq G, Nijs M, Coune A, Vermeulen A, Paridaens R. Tueni E, et al. Among authors: devleeschouwer n. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1461-7. doi: 10.1016/0277-5379(87)90087-3. Eur J Cancer Clin Oncol. 1987. PMID: 2824205

5

In vitro studies of canine mammary tumors: influence of 17-beta-estradiol and progesterone on cell kinetics parameters.

Lespagnard L, Kiss R, Danguy A, Legros N, Lenglet G, Devleeschouwer N, Paridaens R. Lespagnard L, et al. Among authors: devleeschouwer n. Oncology. 1987;44(5):292-301. doi: 10.1159/000226498. Oncology. 1987. PMID: 3670796

6

Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line.

Devleeschouwer N, Body JJ, Legros N, Muquardt C, Donnay I, Wouters P, Leclercq G. Devleeschouwer N, et al. Anticancer Res. 1992 May-Jun;12(3):789-94. Anticancer Res. 1992. PMID: 1622138

7

Induction of progesterone receptor in an estrogen, progesterone receptor-negative breast cancer cell line.

Devleeschouwer N, Olea-Serrano N, Leclercq G, Legros N, Heuson JC. Devleeschouwer N, et al. J Steroid Biochem. 1986 Jan;24(1):365-8. doi: 10.1016/0022-4731(86)90083-x. J Steroid Biochem. 1986. PMID: 3702420

8

In vitro testing of cytotoxic compounds in hormone-dependent and -independent breast cancer cell lines.

Leclercq G, Devleeschouwer N, Heuson JC. Leclercq G, et al. Among authors: devleeschouwer n. Cancer Treat Rev. 1984 Mar;11 Suppl A:163-72. doi: 10.1016/0305-7372(84)90056-2. Cancer Treat Rev. 1984. PMID: 6733716 No abstract available.

9

Estrogen-linked cytotoxic agents of potential value for the treatment of breast cancer.

Leclercq G, Devleeschouwer N, Legros N, Heuson JC. Leclercq G, et al. Among authors: devleeschouwer n. Eur J Cancer (1965). 1980;Suppl 1:287-93. Eur J Cancer (1965). 1980. PMID: 7318866 No abstract available.

10

Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture.

Olea-Serrano N, Devleeschouwer N, Leclercq G, Heuson JC. Olea-Serrano N, et al. Among authors: devleeschouwer n. Eur J Cancer Clin Oncol. 1985 Aug;21(8):965-73. doi: 10.1016/0277-5379(85)90116-6. Eur J Cancer Clin Oncol. 1985. PMID: 4043179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters